-
-
-
-
-
-
-
Teleflex (TFX) PT Raised to $147 at Needham
-
-
-
-
-
-
-
Needham Reiterates Hold Rating on Teleflex (TFX)
-
-
-
-
-
-
-
Teleflex (TFX) Completes Acquisition of BIOTRONIK’s Vascular Intervention Business
-
-
-
-
-
-
-
Wall Street analysts downgrade Teleflex on challenging growth outlook
-
-
-
-
-
-
-
Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business
-
-
-
-
-
-
-
Teleflex Announces Second Quarter 2024 Earnings Conference Call Information
-
-
-
-
-
-
-
Teleflex (TFX) Tops Q3 EPS by 37c, updates guidance
-
1,197,283 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

